BLRX

BioLineRX
BLRX

Overview Fund Activity

26 hedge funds and large institutions have $7.28M invested in BioLineRX in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$612K
2
VKH
2
Virtu KCG Holdings
New York
$138K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$40K
4
TSS
4
Two Sigma Securities
New York
$21K
5
Bank of America
5
Bank of America
North Carolina
$17K

Top Sellers

1
BC
1
Broadfin Capital
New York
$0
2
Millennium Management
2
Millennium Management
New York
$510K
3
SM
3
Senvest Management
New York
$3.62M
4
Morgan Stanley
4
Morgan Stanley
New York
$441K
5
AL
5
Airain Ltd
Guernsey
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$1K +$1K +2 New
BC
27
Broadfin Capital
New York
– -$4.55M -5,833 Closed
AL
28
Airain Ltd
Guernsey
– -$19K -24 Closed
Jane Street
29
Jane Street
New York
– -$16K -20 Closed
TRCT
30
Tower Research Capital (TRC)
New York
– -$2K -3 Closed
1
2